NCT04673942 2024-10-26
BETA-PRIME
EpicentRx, Inc.
Phase 2 Recruiting
Clinical Trials
3 trialsNCT04606108 2020-10-28
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04239443 2020-01-27
Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer
Hunan Cancer Hospital
Phase 2 Unknown